<DOC>
	<DOCNO>NCT00812279</DOCNO>
	<brief_summary>The overall purpose clinical study conduct confinement well-defined condition obtain initial data level human body exposure select smoke constituent SMAR cigarette . The main objective study compare biomarkers exposure cigarette smoke constituent smoker switch SMAR biomarkers smoker conventional cigarette ( CC ) . The biomarkers exposure measure blood urine sample collect subject . Moreover , biomarkers subject smoke conventional SMAR cigarette compare biomarkers smoker stop smoke 5 day . The short term safety new product also evaluate .</brief_summary>
	<brief_title>Investigate Exposure Selected Smoke Constituents Smokers Switching Distillation Based Smoking Article</brief_title>
	<detailed_description>This control , randomise , open-label , 3-arm parallel single centre confinement study investigate exposure select smoke constituent smoker switch CC SMAR 5 day . 112 eligible subject randomise 3 study arm : SMAR , conventional cigarette ( CC ) smoke cessation ( SC ) 2:1:1 ratio . Following screen visit ( within 4 week prior day admission ) , study run 8-day period confine environment , consist admission day ( D-2 ) , 2-day baseline period ( D-1 D0 ) , 5-day exposure period ( D1 D5 ) . Subjects discharge morning D6 . From discharge subject , 7-day safety follow-up period carry ( D13 ) .</detailed_description>
	<criteria>Caucasian adult smoker ( male female ) , acceptable health condition , age 23 55 year usually smoke 10 30 nonmentholated conventional cigarette ( maximum ISO tar yield 10 mg ) per day , least last 5 consecutive year , enrol study . woman childbearing potential must exclude : Subject pregnant ( negative pregnancy test screen D2 ) breastfeeding/ subject agree use acceptable method effective contraception : intrauterine device , intrauterine system , establish use oral/injectable/implantable/ transdermal hormonal method , barrier method contraception ( condom , occlusive cap ) spermicidal foam/gel/film/suppository , vasectomised partner true abstinence ( periodic abstinence withdrawal effective method ) end safety followup period .</criteria>
	<gender>All</gender>
	<minimum_age>23 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>Smokers acceptable health condition</keyword>
</DOC>